Drug Profile


Alternative Names: ND-907; NS-907; REC-152053

Latest Information Update: 16 Jul 1997

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Recordati
  • Developer Dainippon Pharmaceutical; Nippon Shinyaku
  • Class
  • Mechanism of Action Calcium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Urination disorders

Most Recent Events

  • 16 Jul 1997 Discontinued-Clinical for Urination disorders in European Union (PO)
  • 16 Jul 1997 Discontinued-II for Urination disorders in Japan (PO)
  • 30 May 1996 Discontinued-II for Urinary incontinence in Germany (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top